Unknown OBSERVATIONAL NCT03062826

EROSION II: OCT Guided PPCI in STEMI

A Prospective, Multi-center, Optical Coherence Tomography Guided Reperfusion Strategy in Patients With STEMI (EROSION II)

Sponsor: Affiliated Hospital of Jiangsu University

Conditions ST-segment Elevation Myocardial Infarction

Interventions dual antiplatelet therapy (aspirin + ticagrelor or aspirin + clopidogrel)

Updated 11 times since 2017 Last updated: Jun 23, 2022 Started: Jan 11, 2017 Primary completion: Feb 24, 2022 Completion: Mar 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates ST-segment Elevation Myocardial Infarction and is currently ongoing. Affiliated Hospital of Jiangsu University leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Active Not Recruiting → Unknown
Oct 2022 — Jul 2024 [monthly]

Active Not Recruiting
Jul 2022 — Oct 2022 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Feb 2022 — Jul 2022 [monthly]

Recruiting

Status: Unknown Status → Recruiting

▶ Show 6 earlier versions

Oct 2021 — Feb 2022 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting
Jul 2019 — Jan 2021 [monthly]

Recruiting
Jun 2018 — Jul 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Affiliated Hospital of Jiangsu University
Beijing Luhe Hospital
China-Japan Union Hospital, Jilin University
General Hospital of Ningxia Medical University
Harbin Medical University
Hebei General Hospital
LanZhou University
Second Hospital of Shanxi Medical University
Shanxi Cardiovascular Hospital
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen Sun Yat-sen Cardiovascular Hospital
Sichuan Provincial People's Hospital
Sir Run Run Shaw Hospital
The First Affiliated Hospital of Dalian Medical University
The First Hospital of Jilin University
Wuhan Asia Heart Hospital
Xiamen Cardiovascular Hospital, Xiamen University

Data source: Harbin Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Changchun, China , Chengdu, China , Dalian, China , Hangzhou, China , Harbin, China , Lanzhou, China , Shenzhen, China , Shijiazhuang, China , Taiyuan, China and 4 more locations